Here are eight things to know about the spinal fusion market.
1. The global spinal fusion devices market is expected to hit $8.1 billion by 2027, according to a November 2020 Reportlinker release.
2. The U.S. spinal fusion devices market is estimated at $1.9 billion and expected to grow at a 3.3 compound annual growth rate from 2020 to 2027 and reach $4.7 billion, according to Reportlinker.
3. The U.S. interbody fusions market was valued at $500 million in 2020 and expected to hit $649 million by the end of 2027, according to Reportlinker.
4. The top four companies by revenue in the spine market are:
- Medtronic: 29 percent
- Johnson & Johnson: 16 percent
- NuVasive: 13 percent
- Stryker: 12 percent
This information came from a Spine Market Group report based on 2019 data, the most recent information available.
5. In 2020, there were 153,288 anterior cervical discectomy and fusions performed in the U.S., and a study published in World Neurosurgery expects volume to increase 13.3 percent through 2040. The study also estimated posterior cervical discectomy and fusions would jump 19.3 percent over the next 20 years, from 29,620 in 2020 to 35,335 in 2040.
6. The average 90-day cost of single-level anterior lumbar interbody fusion procedures is $25,568 for Humana Medicare Advantage beneficiaries and $51,741 for commercially insured Humana patients, according to a study published in World Neurosurgery. Three quarters of the overall cost went to facility reimbursement and 9 to 11 percent went to surgeon pay.
7. The cost of spinal fusion varies depending on the setting. Typically, outpatient surgery centers receive lower reimbursement than hospital outpatient departments. For example, CMS pays $10,267 for posterior or posterolateral lumbar fusions in the ASC and $13,560 in the hospital outpatient department.
8. Between 2004 and 2015, the rate of elective lumbar spinal fusions for treating degenerative spine disease increased 276 percent, according to a 2019 study published in the Journal of Neurosurgical Sciences. The most frequent complication was postoperative anemia, appearing in 11.2 percent of patients and adding around $1,817 to the cost of care.